Effect of topical recombinant human nerve growth factor (cenegermin) on corneal sensitivity in patients with neurotrophic keratitis

被引：0
|
作者：
Massaro-Giordano, Mina [1 ]
Macchi, Ilaria [1 ]
Bunya, Vatinee Y. [1 ]
Mantelli, Flavio [2 ]
机构：
[1] Scheie Eye Inst, Ophthalmol, Philadelphia, PA USA
[2] Dompe, Boston, MA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2020年 / 61卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
380
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Topical recombinant human nerve growth factor improves rat corneal epithelial wound healing.
    Ying, HS
    Angeles, A
    Rife, L
    Smith, RE
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S886 - S886
  • [22] Topical Recombinant Human Nerve Growth Factor Improves Outcomes in Murine Model of Neuropathic Corneal Pain
    Kenyon, Brendan
    Harris, Deshea
    Qiu, Fangfang
    Chao, Cecilia
    Seyed-Razavi, Yashar
    Hamrah, Pedram
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [23] Acute Calcific Band Keratopathy as an Adverse Effect of Recombinant Human Nerve Growth Factor (Cenegermin): A Multicenter Case Series
    Qureshi, Sana
    Ferguson, Tanner J.
    Lim, Mira
    You, Jae Young
    Goshe, Jeffrey M.
    Hood, Christopher T.
    CORNEA, 2022, 41 (01) : 52 - 59
  • [24] Long-term clinical efficacy of topical treatment with recombinant human nerve growth factor in neurotrophic keratopathy: a novel cure for a rare degenerative corneal disease?
    Bruscolini, Alice
    Marenco, Marco
    Albanese, Giuseppe Maria
    Lambiase, Alessandro
    Sacchetti, Marta
    ORPHANET JOURNAL OF RARE DISEASES, 2022, 17 (01)
  • [25] Long-term clinical efficacy of topical treatment with recombinant human nerve growth factor in neurotrophic keratopathy: a novel cure for a rare degenerative corneal disease?
    Alice Bruscolini
    Marco Marenco
    Giuseppe Maria Albanese
    Alessandro Lambiase
    Marta Sacchetti
    Orphanet Journal of Rare Diseases, 17
  • [26] Emerging medical and surgical treatments for neurotrophic keratopathy: Review of human recombinant nerve growth factor and corneal neurotisation techniques
    Lee, Brendon W. H.
    Khan, Muhammad
    Ngo, Quan
    Tumuluri, Krishna
    Samarawickrama, Chameen
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 50 (08): : 941 - 942
  • [27] Role of Topical Cenegermin in Management of a Cornea Transplant in a Functionally Monocular Patient with Neurotrophic Keratitis and Facial Nerve Palsy: A Case Report
    Pocobelli, Augusto
    Komaiha, Chiara
    De Carlo, Luca
    Pocobelli, Giulio
    Boni, Nicoletta
    Gisoldi, Rossella Anna Maria Colabelli
    INTERNATIONAL MEDICAL CASE REPORTS JOURNAL, 2020, 13 : 617 - 621
  • [28] Longitudinal Assessment of Epithelial Cell Densities in Neurotrophic Keratitis Patients Treated with Recombinant Human Nerve Growth Factor in vivo via Confocal Microscopy.
    Unno, Nobuyoshi
    Milhomens Filho, Jose Arthur
    Kim, Cinthia
    Karslioglu, Melisa
    Lee, Olivia
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (09)
  • [29] Efficacy of Recombinant Human Nerve Growth Factor in Stage 1 Neurotrophic Keratopathy
    Yavuz Saricay, Leyla
    Bayraktutar, Betul N.
    Lilley, Jonathan
    Mah, Francis S.
    Massaro-giordano, Mina
    Hamrah, Pedram
    OPHTHALMOLOGY, 2022, 129 (12) : 1448 - 1450
  • [30] Phase II Randomized, Double-Masked, Vehicle-Controlled Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis
    Bonini, Stefano
    Lambiase, Alessandro
    Rama, Paolo
    Sinigaglia, Francesco
    Allegretti, Marcello
    Chao, Wendy
    Mantelli, Flavio
    OPHTHALMOLOGY, 2018, 125 (09) : 1332 - 1343
12345